These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21691202)
1. Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine. Boules M; Johnston H; Tozy J; Smith K; Li Z; Richelson E Behav Pharmacol; 2011 Sep; 22(5-6):573-81. PubMed ID: 21691202 [TBL] [Abstract][Full Text] [Related]
2. NT69L, a novel analgesic, shows synergy with morphine. Boules M; Shaw A; Liang Y; Barbut D; Richelson E Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107 [TBL] [Abstract][Full Text] [Related]
3. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain. Smith KE; Boules M; Williams K; Richelson E Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145 [TBL] [Abstract][Full Text] [Related]
4. NT79: A novel neurotensin analog with selective behavioral effects. Boules M; Liang Y; Briody S; Miura T; Fauq I; Oliveros A; Wilson M; Khaniyev S; Williams K; Li Z; Qi Y; Katovich M; Richelson E Brain Res; 2010 Jan; 1308():35-46. PubMed ID: 19874804 [TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain. Guillemette A; Dansereau MA; Beaudet N; Richelson E; Sarret P Eur J Pain; 2012 Apr; 16(4):473-84. PubMed ID: 22396077 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity. Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660 [TBL] [Abstract][Full Text] [Related]
7. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice. Bredeloux P; Costentin J; Dubuc I Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405 [TBL] [Abstract][Full Text] [Related]
8. Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model. Roussy G; Dansereau MA; Doré-Savard L; Belleville K; Beaudet N; Richelson E; Sarret P J Neurochem; 2008 May; 105(4):1100-14. PubMed ID: 18182046 [TBL] [Abstract][Full Text] [Related]
9. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio. Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956 [TBL] [Abstract][Full Text] [Related]
10. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog. Tétreault P; Besserer-Offroy É; Brouillette RL; René A; Murza A; Fanelli R; Kirby K; Parent AJ; Dubuc I; Beaudet N; Côté J; Longpré JM; Martinez J; Cavelier F; Sarret P Eur J Pharmacol; 2020 Sep; 882():173174. PubMed ID: 32534076 [TBL] [Abstract][Full Text] [Related]
11. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Kitabgi P Curr Opin Drug Discov Devel; 2002 Sep; 5(5):764-76. PubMed ID: 12630297 [TBL] [Abstract][Full Text] [Related]
12. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H. Gallantine EL; Meert TF Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: influence on the antinociceptive effect of morphine. Smith DJ; Hawranko AA; Monroe PJ; Gully D; Urban MO; Craig CR; Smith JP; Smith DL J Pharmacol Exp Ther; 1997 Aug; 282(2):899-908. PubMed ID: 9262357 [TBL] [Abstract][Full Text] [Related]
15. Involvement of NTS2 receptors in stress-induced analgesia. Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838 [TBL] [Abstract][Full Text] [Related]
16. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens. Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912 [TBL] [Abstract][Full Text] [Related]
17. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice. Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157 [TBL] [Abstract][Full Text] [Related]
18. Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5. Hua XY; Hayes CS; Hofer A; Fitzsimmons B; Kilk K; Langel U; Bartfai T; Yaksh TL J Pharmacol Exp Ther; 2004 Feb; 308(2):574-82. PubMed ID: 14610237 [TBL] [Abstract][Full Text] [Related]
19. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia. Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400 [TBL] [Abstract][Full Text] [Related]
20. Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists. Sevostianova N; Danysz W; Bespalov AY Eur J Pharmacol; 2005 Nov; 525(1-3):83-90. PubMed ID: 16297905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]